Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: Implications for neuroinflammation and neurodegeneration

Journal of Neuroimmunology

Volumn 109, Issue 2, 2000, Pages 221-227

  Vos, Catharina M P ^a,b   Gartner, Suzanne ^a   Ransohoff, Richard M ^c   McArthur, Justin C ^a,d   Wahl, Larry ^e   Sjulson, Lucas ^a   Hunter, Edward ^a   Conant, Katherine ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LERNER RESEARCH INSTITUTE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

CCR 2; MCP 1; MMP 9; Monocytes

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; GELATINASE B; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMENTIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; GELATINASE B; HUMAN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MONOCYTES; NERVE DEGENERATION; NEURITIS; RECEPTORS, CHEMOKINE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034703293     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00308-8     Document Type: Article

References (38)

1. Anthony D.C., Miller K.M., Fearn S., Townsend M.J., Opdenakker G., Wells G.N., Clements J.M., Chandler S., Gearing A.J., Perry V.H. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol. 87:1998;67-72.
2. Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese R.V., Broxmeyer H.E., Charo I.F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invt. 100:1997;2552-2561.
3. Bozzo C., Bellomo G., Silengo L., Tarone G., Altruda F. Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions. Exp. Cell. Res. 237:(2):1997;326-337.
4. Cinque P., Vago L., Mengozzi M., Torri V., Ceresa D., Vicenzi E., Transidico P., Vagani A., Sozzani S., Mantovani A., Lazzarin A., Poli G. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS. 12:(11):1998;1327-1332.
5. Conant K., Garzino-Demo A., Nath A., McArthur J.C., Halliday W., Power C., Gallo R.C., Major E.O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA. 95:1998;3117-3121.
6. Dawson T.C., Kuziel W.A., Osahar T.A., Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 143:(1):1999;205-211.
7. Epstein L.G., Gendelman H.E. Human immunodeficiency virus type-1 infection of the nervous system:pathogenetic mechanisms. Ann. Neurol. 33:1993;429-436.
8. Fantuzzi L., Borghi P., Ciolli V., Pavlakis G., Belardelli F., Gessani S. Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response. Blood. 94:(3):1999;875-883.
9. Gartner S. AIDS: HIV infection and dementia. Science. 287:2000;602-604.
10. Gartner S., Popovic M. Virus isolation and production. Aldovini A., Walker B.D. Techniques in HIV Research. 1990;Stockton Press, NY. Chapter 3.
11. Glass J.D., Fedor H.S., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:1995;755-762.
12. Gruenbaum L.M., Carew T.J. Growth factor modulation of substrate-specific morphological patterns in Aplysia bag cell neurons. Learn Mem. 6:1999;292-306.
13. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:(2):1998;275-281.
14. Herkenham M., Lee H.Y., Baker R.A. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J. Comp. Neurol. 400:(2):1998;175-196.
15. Houweling D.A., Lankhorst A.J., Gispen W.H., Bar P.R., Joosten E.A. Collagen containing neurotrophin-3 (NT-3) attracts regrowing injured corticospinal axons in the adult rat spinal cord and promotes partial functional recovery. Exp. Neurol. 153:1998;49-59.
16. Karpus W.J., Lukacs N.W. The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with anti-monocyte chemotactic protein-1. Ann. N.Y. Acad. Sci. USA. 778:1996;133-134.
17. Kelder, W., McArthur, J.C., Nance-Sproson, T., Lanier, R., Griffin, D.E., 1998. β-chemokines MCP-1 and RANTES are increased in cerebrospinal fluid of patients with HIV-associated dementia. Ann. Neurol.
18. Kitagawa S., You A., Yagisawa M., Azuma E., Yoshida M., Furukawa Y., Takahashi M., Masuyama J., Takaku F. Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release. Exp. Hematol. 24:1996;559-567.
19. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1997;1757-1762.
20. Kuroiwa T., Lee E.G., Danning C.L., Illei G.G., McInnes I.B., Boumpas D.T. CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms. J. Immunol. 163:(4):1999;2168-2175.
21. Kuziel, W.A., Morgan, S.J., Dawson, T.C., Griffin, S., Smithies, O., Ley, K., Maeda, N., 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA, 12503-12508.
22. Leppert D., Waubant E., Burk M.R., Oksenberg J.R., Hauser S.L. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol. 40:(6):1996;846-852.
23. Leppert D., Waubant E., Galardy R., Bunnett N.W., Hauser S.L. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154:(9):1995;4379-4389.
24. Libby R.T., Lavallee C.R., Balkema G.W., Brunken W.J., Hunter D.D. Disruption of laminin beta2 chain production causes alterations in morphology and function in the CNS. J. Neurosci. 19:(21):1999;9399-9411.
25. Lu B., Rutledge B., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1 deficient mice. J. Exp. Med. 187:1998;601-608.
26. Nichol K.A., Schulz M.W., Bennett M.R. Nitric oxide-mediated death of cultured neonatal retinal ganglion cells: neuroprotective properties of glutamate and chondroitin sulfate proteoglycan. Brain Res. 697:(1-2):1995;1-16.
27. Owen C.A., Campbell M.A., Boukedes S.S., Campbell E.J. Monocytes recruited to sites of inflammation express a distinctive proinflammatory (P) phenotype. Am. J. Physiol. 267:1994;L786-L796.
28. Penton-Rol G., Polentarutti N., Luini W., Borsatti A., Mancinelli R., Sica A., Sozzani S. Mantovani A Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. J. Immunol. 160:(8):1998;3869-3873.
29. Pulliam L., Gascon R., Stubblebine M., McGuire D., McGrath M.S. Unique monocyte subset in patients with AIDS dementia. Lancet. 349:1997;692-695.
30. Rosenberg G.A., Kornfeld M., Estrada E., Liotta L.A., Statler-Stevenson W.G. TIMP-2 reduces proteolytic opening of the blood brain barrier by type IV collagenase. Brain Res. 576:1992;203-207.
31. Sasseville V.G., Newman W.A., Lackner A.A., Smith M.O., Lausen N.C.G., Beall D., Ringler D.J. Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am. J. Pathol. 141:1992;1021-1030.
32. Schonbeck U., Mach F., Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1beta processing. J. Immunol. 161:1998;3340-3346.
33. Uguccioni M., D'Apuzzo M., Loetscher M., Dewald B., Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur. J. Immunol. 25:(1):1995;64-68.
34. Weber C., Draude G., Weber K.S., Wubert J., Lorenz R.L., Weber P.C. Downregulation by tumor necrosis factor-alpha of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: a potential mechanism of monocyte retention in atherosclerotic lesions. Atherosclerosis. 145:(1):1999;115-123.
35. Weber K.S.C., von Hundelshausen P., Clark-Lewis I., Weber P.C., Weber C. Differential immobilization and hierarchial involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur. J. Immunol. 29:1999;700-712.
36. Wee Yong V., Krekoski C.A., Forsyth P.A., Bell R., Edwards D.R. Matrix metalloproteinases and diseases of the CNS. TINS. 21:1998;75-80.
37. Weiss J.M., Downie S.A., Lyman W.D., Berman J.W. Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J. Immunol. 161:(12):1998;6896-6903.
38. Zhang Y., McCluskey K., Fujii K., Wahl L.M. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through and -independent mechanisms. J. Immunol. 161:(6):1998;3071-3076.